SCHEMBL24569508

SCHEMBL24569508

CC(C)(C)OC(=O)N1CCC(C(O)[C@@H]2CCCN2C(=O)OC(C)(C)C)C1=O

nearest known ligand 0.42

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
PDE4A P27815 1/20 0.42
PDE4B Q07343 1/20 0.42
PDE4C Q08493 1/20 0.42
PDE4D Q08499 1/20 0.42
HSD17B10 Q99714 1/20 0.41
NPC1 O15118 1/20 0.39
UCHL1 P09936 1/20 0.39
ALDH1A1 P00352 2/20 0.38
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
LMNA P02545 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.37
TSHR P16473 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29888033 1.00 PDE4A (0.42) PDE4APDE4BPDE4CPDE4DHSD17B10
SCHEMBL24569510 1.00 PDE4A (0.42) PDE4APDE4BPDE4CPDE4DHSD17B10
SCHEMBL29888024 0.83 MEN1 (0.38) PDE4APDE4BPDE4CPDE4DHSD17B10
SCHEMBL29888051 0.83 MEN1 (0.38) PDE4APDE4BPDE4CPDE4DHSD17B10
SCHEMBL25970732 0.80 HSD17B10 (0.45) HSD17B10NPC1UCHL1ALDH1A1MEN1
SCHEMBL25970778 0.80 HSD17B10 (0.45) HSD17B10NPC1UCHL1ALDH1A1MEN1
SCHEMBL25971820 0.80 HSD17B10 (0.45) HSD17B10NPC1UCHL1ALDH1A1MEN1
SCHEMBL9387477 0.79 PDE4A (0.45) PDE4APDE4BPDE4CPDE4DNPC1
SCHEMBL20256229 0.79 HSD17B10 (0.49) HSD17B10NPC1UCHL1ALDH1A1MEN1
SCHEMBL22139321 0.79 HSD17B10 (0.49) HSD17B10NPC1UCHL1ALDH1A1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4267137-A1 LACTAM (HETERO)ARYLFUSEDPYRIMIDINE DERIVATIVES AS INHIBITORS OF ERBB2 Enliven Inc. (US) 2023-11-01 EP disclosed
WO-2022140769-A1 LACTAM (HETERO)ARYLFUSEDPYRIMIDINE DERIVATIVES AS INHIBITORS OF ERBB2 ENLIVEN THERAPEUTICS, INC. (US) 2022-06-30 WO disclosed
WO-2022140769-A1 LACTAM (HETERO)ARYLFUSEDPYRIMIDINE DERIVATIVES AS INHIBITORS OF ERBB2 ENLIVEN THERAPEUTICS, INC. (US) 2022-06-30 WO disclosed